| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/06/2005 | US20050220705 Methods for treating non-melanoma cancers with PABA |
| 10/06/2005 | CA2561192A1 Cancerous disease modifying antibodies |
| 10/06/2005 | CA2560864A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 10/06/2005 | CA2560862A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 10/06/2005 | CA2558738A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 10/05/2005 | EP1581812A2 Compositions and methods for diagnosing and treating colon cancers |
| 10/05/2005 | EP1581790A2 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 10/05/2005 | EP1581538A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 10/05/2005 | EP1581262A2 Contrast agent |
| 10/05/2005 | EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 10/05/2005 | EP1163231B1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics |
| 10/05/2005 | EP1001977B1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
| 10/05/2005 | CN1678353A New anti-cancer compounds |
| 10/05/2005 | CN1678348A Compositions and methods for therapeutic treatment |
| 10/05/2005 | CN1678347A Antibodies and uses thereof |
| 10/05/2005 | CN1221250C Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 10/04/2005 | US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma |
| 10/04/2005 | US6951640 Imaging tumors using organometallic porphyrin |
| 10/04/2005 | US6951639 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
| 09/29/2005 | WO2005089912A1 Gallium-68 |
| 09/29/2005 | WO2005089815A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 09/29/2005 | WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents |
| 09/29/2005 | WO2005029066A3 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 09/29/2005 | WO2004101737A3 A novel adjuvant capable of specifically activating the adaptive immune response |
| 09/29/2005 | WO2004062722A3 Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers |
| 09/29/2005 | WO2004002308A3 Management of gastro-intestinal disorders |
| 09/29/2005 | WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
| 09/29/2005 | US20050215873 Imaging method and device for carrying out said method |
| 09/29/2005 | US20050214868 Using receptor binding site as base module for dual specificity recognition molecule; drug screening and design |
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214284 Soluble TCR molecules and methods of use |
| 09/29/2005 | US20050214211 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/29/2005 | US20050214208 Anitcancer and antiproliferative agents; tumor necrosis factor related apoptosis inducing ligand (TRAIL); combination of amino acid sequences from VHCDR1, 2 or 3 with VLCDR1, 2 or 3 of sequence numbers 42 through 56; isolated cells; kits |
| 09/29/2005 | US20050214207 Antibodies that immunospecifically bind toTRAIL receptors |
| 09/29/2005 | US20050214206 Antibodies that immunospecifically bind to TRAIL receptors |
| 09/29/2005 | US20050214205 Antibodies that immunospecifically bind to TRAIL receptors |
| 09/29/2005 | US20050214204 [18F][2-fluorodideuteromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine; image of neurokinin-1 receptors using positron emission tomography; detection or quantification; bioassay; brain, tissues, inflammation where substance P is involved, Alzheimer's disease |
| 09/29/2005 | DE102004011720A1 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578456A1 Isotope labeled camptothecin derivatives |
| 09/28/2005 | EP1578455A2 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 09/28/2005 | EP1578440A1 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 09/28/2005 | EP1578253A2 Prevention and treatment of synucleinopathic disease |
| 09/28/2005 | EP1578193A2 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| 09/28/2005 | EP1296722B1 Radiotherapy |
| 09/28/2005 | CN1675245A Monoclonal antibody hPAM4 |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1674943A Radioactively labelled amino acid analogues, their preparation and use |
| 09/28/2005 | CN1672734A Degradable particle source for local radiotherapy |
| 09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | CA2241825C New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy |
| 09/22/2005 | WO2005087275A2 Metal radiolabeled pet imaging agents |
| 09/22/2005 | WO2005087274A1 Particulate materials and compositions for radio therapy |
| 09/22/2005 | WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/22/2005 | WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery |
| 09/22/2005 | WO2005086639A2 Improved efficacy and safety of targeted particulate agents with decoy systems |
| 09/22/2005 | WO2005086612A2 Fluorinated carbohydrate conjugates |
| 09/22/2005 | US20050208498 Killer cell immunoglobulin-like receptor (KIR)-like protein receptor for use in diagnosis, prevention and treatment of cancer, autoimmune disease, organ transplant rejection, allergic reaction, and inflammatory disorders |
| 09/22/2005 | US20050208138 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent; drug delivery method; sustained releasing the biodrug |
| 09/22/2005 | US20050207987 Mixture of tobramycin in carrier; aerosols; respiratory system disorders; drug delivery |
| 09/22/2005 | US20050207975 administering monoclonal Tac-antibodies; anticarcinogenic agents; immunotherapy |
| 09/22/2005 | US20050207974 antibodies, fragments or ligands that specifically binds to polypeptides or polynucleotides that are differentially expressed in vascular endothelial cells, conjugated to drugs or cytotoxic agents such as angiogenesis inhibitors or activators; treatment of vascular diseases; inhibiting tumor growth |
| 09/22/2005 | US20050207973 Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy chromans |
| 09/22/2005 | US20050207972 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 09/22/2005 | CA2555343A1 Improved efficacy and safety of targeted particulate agents with decoy systems |
| 09/22/2005 | CA2533878A1 Fluorinated carbohydrate conjugates |
| 09/21/2005 | EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 09/21/2005 | EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/21/2005 | EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque |
| 09/21/2005 | EP1404377B1 Improved chelator conjugates |
| 09/21/2005 | EP1194174B1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 09/21/2005 | EP1028756B1 Water soluble paclitaxel conjugates combined with irradiation for the treatment of cancer |
| 09/21/2005 | CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 09/21/2005 | CN1671399A Myocardial perfusion imaging using A2A receptor agonists |
| 09/21/2005 | CN1669586A Tracer or labelled isotope microbubble reagent with target substance and usage thereof |
| 09/21/2005 | CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 09/21/2005 | CN1219551C Conjugates made of metal complexes and oligonucleotides |
| 09/20/2005 | US6946116 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/20/2005 | CA2137243C Process for the production of n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl -1,4,7,10-tetraazacyclododecane and n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11- tetraazacyclotetradecane derivatives and their metal compllexes |
| 09/15/2005 | WO2005084716A2 Phospholipid analogs for diagnosis and treatment of cancer |
| 09/15/2005 | WO2005084715A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 09/15/2005 | WO2005084179A2 Improved method for preparing conjugates of proteins and chelating agents |
| 09/15/2005 | WO2004084823A3 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 09/15/2005 | US20050203331 Neurosurgical instrument with gamma ray detector |
| 09/15/2005 | US20050203330 Disposable saline water cartridge module for radiopharmaceuticals dispensing and injection system |
| 09/15/2005 | US20050203329 Dispensing and injection system for radiopharmaceuticals |
| 09/15/2005 | US20050201947 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 09/15/2005 | US20050201934 Binding peptides for carcinoembryonic antigen (CEA) |
| 09/15/2005 | US20050201933 Macrocyclic chelants for metallopharmaceuticals |
| 09/15/2005 | US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 09/15/2005 | US20050201931 LAT1 transporters expressed in blood brain barrier cells |
| 09/15/2005 | US20050201930 Ultrasonic contrast agents; aqueous suspension |
| 09/15/2005 | DE102005010154A1 Systeme, Verfahren und Vorrichtungen für die Infusion von Radiopharmazeutika Systems, methods and devices for the infusion of radiopharmaceuticals |
| 09/15/2005 | DE102005010152A1 Systeme, Verfahren und Vorrichtungen für die Zubereitung, Förderung und Überwachung von Radiopharmazeutika Systems, methods and apparatus for the preparation, promotion and monitoring of radiopharmaceuticals |
| 09/15/2005 | CA2558408A1 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 09/15/2005 | CA2557698A1 Phospholipid analogs as diapeutic* agents and methods therefor |
| 09/14/2005 | EP1574500A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 09/14/2005 | EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 09/14/2005 | EP1572747A2 Tumor-specific recognition molecules |